Journal of Clinical Endocrinology & Metabolism, Vol 54, 254-260, Copyright © 1982 by Endocrine Society

ARTICLES

Relation of body fat distribution to metabolic complications of obesity

AH Kissebah, N Vydelingum, R Murray, DJ Evans, AJ Hartz, RK Kalkhoff and PW Adams

The importance of body fat distribution as a predictor of metabolic aberrations was evaluated in 9 nonobese and 25 obese, apparently healthy women. Plasma glucose and insulin levels during oral glucose loading were significantly higher in women with predominantly upper body segment obesity than in women with lower body segment obesity. Of the former group, 10 of 16 subjects had diabetic glucose tolerance results, while none of the latter group was diabetic. Fasting plasma triglyceride levels were also significantly higher in the upper body segment obese women. The site of adiposity in the upper body segment obese women was comprised of large fat cells, while in the lower body segment obese subjects, it was formed of normal size cells. In both types of obesity, abdominal fat cell size correlated significantly with postprandial plasma glucose and insulin levels. Thigh fat cell size gave no indication as to the presence of metabolic complications. Thigh adipocytes were also resistant to epinephrine-stimulated lipolysis, presumably due to an increase in alpha-adrenergic receptors. Thus, in women, the sites of fat predominance offer an important prognostic marker for glucose intolerance, hyperinsulinemia, and hypertriglyceridemia. This association may be related to the disparate morphology and metabolic behavior of fat cells associated with different body fat distributions.

This article has been cited by other articles:

				J. A. Meyerhardt, D. Niedzwiecki, D. Hollis, L. B. Saltz, R. J. Mayer, H. Nelson, R. Whittom, A. Hantel, J. Thomas, and C. S. Fuchs Impact of Body Mass Index and Weight Change After Treatment on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From Cancer and Leukemia Group B 89803 J. Clin. Oncol., September 1, 2008; 26(25): 4109 - 4115. [Abstract] [Full Text] [PDF]

				L. Landsberg Body Fat Distribution and Cardiovascular Risk: A Tale of 2 Sites Arch Intern Med, August 11, 2008; 168(15): 1607 - 1608. [Full Text] [PDF]

				J. Huber, F. W. Kiefer, M. Zeyda, B. Ludvik, G. R. Silberhumer, G. Prager, G. J. Zlabinger, and T. M. Stulnig CC Chemokine and CC Chemokine Receptor Profiles in Visceral and Subcutaneous Adipose Tissue Are Altered in Human Obesity J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3215 - 3221. [Abstract] [Full Text] [PDF]

				I. Ioannidis The Road From Obesity to Type 2 Diabetes Angiology, August 1, 2008; 59(2_suppl): 39S - 43S. [Abstract] [PDF]

				M. Zeller, P. G. Steg, J. Ravisy, L. Lorgis, Y. Laurent, P. Sicard, L. Janin-Manificat, J.-C. Beer, H. Makki, A.-C. Lagrost, et al. Relation Between Body Mass Index, Waist Circumference, and Death After Acute Myocardial Infarction Circulation, July 29, 2008; 118(5): 482 - 490. [Abstract] [Full Text] [PDF]

				A. P. Jayasooriya, M. L. Mathai, L. L. Walker, D. P. Begg, D. A. Denton, D. Cameron-Smith, G. F. Egan, M. J. McKinley, P. D. Rodger, A. J. Sinclair, et al. Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance PNAS, May 6, 2008; 105(18): 6531 - 6536. [Abstract] [Full Text] [PDF]

				G. A Bray, K. A Jablonski, W. Y Fujimoto, E. Barrett-Connor, S. Haffner, R. L Hanson, J. O Hill, V. Hubbard, A. Kriska, E. Stamm, et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1212 - 1218. [Abstract] [Full Text] [PDF]

				P. M. Janiszewski, T. J. Saunders, and R. Ross Themed Review: Lifestyle Treatment of the Metabolic Syndrome American Journal of Lifestyle Medicine, April 1, 2008; 2(2): 99 - 108. [Abstract] [PDF]

				J.-P. Despres, P. Poirier, J. Bergeron, A. Tremblay, I. Lemieux, and N. Almeras From individual risk factors and the metabolic syndrome to global cardiometabolic risk Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B24 - B33. [Abstract] [Full Text] [PDF]

				Y. D Tchoukalova, C. Koutsari, M. V Karpyak, S. B Votruba, E. Wendland, and M. D Jensen Subcutaneous adipocyte size and body fat distribution Am. J. Clinical Nutrition, January 1, 2008; 87(1): 56 - 63. [Abstract] [Full Text] [PDF]

				Y. Okauchi, H. Nishizawa, T. Funahashi, T. Ogawa, M. Noguchi, M. Ryo, S. Kihara, H. Iwahashi, K. Yamagata, T. Nakamura, et al. Reduction of Visceral Fat Is Associated With Decrease in the Number of Metabolic Risk Factors in Japanese Men Diabetes Care, September 1, 2007; 30(9): 2392 - 2394. [Full Text] [PDF]

				J. A. Morrison, L. A. Friedman, and C. Gray-McGuire Metabolic Syndrome in Childhood Predicts Adult Cardiovascular Disease 25 Years Later: The Princeton Lipid Research Clinics Follow-up Study Pediatrics, August 1, 2007; 120(2): 340 - 345. [Abstract] [Full Text] [PDF]

				B. A.J. Verhage, L. J. Schouten, R. A. Goldbohm, and P. A. van den Brandt Anthropometry and Pancreatic Cancer Risk: An Illustration of the Importance of Microscopic Verification Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1449 - 1454. [Abstract] [Full Text] [PDF]

				K. Azuma, L. K. Heilbronn, J. B. Albu, S. R. Smith, E. Ravussin, D. E. Kelley, and and the Look AHEAD Adipose Research Group Adipose tissue distribution in relation to insulin resistance in type 2 diabetes mellitus Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E435 - E442. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74. [Full Text] [PDF]

				S. Klein, D. B. Allison, S. B. Heymsfield, D. E. Kelley, R. L. Leibel, C. Nonas, and R. Kahn Waist Circumference and Cardiometabolic Risk: A Consensus Statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association Diabetes Care, June 1, 2007; 30(6): 1647 - 1652. [Full Text] [PDF]

				W. Y. Fujimoto, K. A. Jablonski, G. A. Bray, A. Kriska, E. Barrett-Connor, S. Haffner, R. Hanson, J. O. Hill, V. Hubbard, E. Stamm, et al. Body Size and Shape Changes and the Risk of Diabetes in the Diabetes Prevention Program Diabetes, June 1, 2007; 56(6): 1680 - 1685. [Abstract] [Full Text] [PDF]

				S. Klein, D. B Allison, S. B Heymsfield, D. E Kelley, R. L Leibel, C. Nonas, and R. Kahn Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1197 - 1202. [Full Text] [PDF]

				B. W. McCrindle, E. M. Urbina, B. A. Dennison, M. S. Jacobson, J. Steinberger, A. P. Rocchini, L. L. Hayman, and S. R. Daniels Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing Circulation, April 10, 2007; 115(14): 1948 - 1967. [Abstract] [Full Text] [PDF]

				S. Bhasin, R. A. Parker, F. Sattler, R. Haubrich, B. Alston, T. Umbleja, C. M. Shikuma, and for the AIDS Clinical Trials Group Protocol A5079 Effects of Testosterone Supplementation on Whole Body and Regional Fat Mass and Distribution in Human Immunodeficiency Virus-Infected Men with Abdominal Obesity J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1049 - 1057. [Abstract] [Full Text] [PDF]

				J. C. Wells, P. Treleaven, and T. J Cole BMI compared with 3-dimensional body shape: the UK National Sizing Survey Am. J. Clinical Nutrition, February 1, 2007; 85(2): 419 - 425. [Abstract] [Full Text] [PDF]

				E. Friberg, C. S. Mantzoros, and A. Wolk Diabetes and Risk of Endometrial Cancer: A Population-Based Prospective Cohort Study Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 276 - 280. [Abstract] [Full Text] [PDF]

				A Majuri, M Santaniemi, K Rautio, A Kunnari, J Vartiainen, A Ruokonen, Y A Kesaniemi, J S Tapanainen, O Ukkola, and L Morin-Papunen Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study Eur. J. Endocrinol., February 1, 2007; 156(2): 263 - 269. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J., January 1, 2007; 28(1): 88 - 136. [Full Text] [PDF]

				M. Hoenig, K. Thomaseth, M. Waldron, and D. C. Ferguson Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R227 - R234. [Abstract] [Full Text] [PDF]

				G. L. Vega, B. Adams-Huet, R. Peshock, D. Willett, B. Shah, and S. M. Grundy Influence of Body Fat Content and Distribution on Variation in Metabolic Risk J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4459 - 4466. [Abstract] [Full Text] [PDF]

				E. Friberg, C. S. Mantzoros, and A. Wolk Physical Activity and Risk of Endometrial Cancer: A Population-Based Prospective Cohort Study Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2136 - 2140. [Abstract] [Full Text] [PDF]

				S. B. Votruba and M. D. Jensen Sex-specific differences in leg fat uptake are revealed with a high-fat meal Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1115 - E1123. [Abstract] [Full Text] [PDF]

				M. Laplante, W. T. Festuccia, G. Soucy, Y. Gelinas, J. Lalonde, J. P. Berger, and Y. Deshaies Mechanisms of the Depot Specificity of Peroxisome Proliferator-Activated Receptor {gamma} Action on Adipose Tissue Metabolism. Diabetes, October 1, 2006; 55(10): 2771 - 2778. [Abstract] [Full Text] [PDF]

				K. McAuley and J. Mann Thematic review series: Patient-Oriented Research. Nutritional determinants of insulin resistance J. Lipid Res., August 1, 2006; 47(8): 1668 - 1676. [Abstract] [Full Text] [PDF]

				G. M Reaven The metabolic syndrome: is this diagnosis necessary? Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1237 - 1247. [Abstract] [Full Text] [PDF]

				C-J Tsai, M F Leitzmann, W C Willett, and E L Giovannucci Central adiposity, regional fat distribution, and the risk of cholecystectomy in women Gut, May 1, 2006; 55(5): 708 - 714. [Abstract] [Full Text] [PDF]

				B. Gustafson and U. Smith Cytokines Promote Wnt Signaling and Inflammation and Impair the Normal Differentiation and Lipid Accumulation in 3T3-L1 Preadipocytes J. Biol. Chem., April 7, 2006; 281(14): 9507 - 9516. [Abstract] [Full Text] [PDF]

				M. Warren, P. J. Schreiner, and J. G. Terry The Relation between Visceral Fat Measurement and Torso Level--Is One Level Better Than Another?: The Atherosclerosis Risk in Communities Study, 1990-1992 Am. J. Epidemiol., February 15, 2006; 163(4): 352 - 358. [Abstract] [Full Text] [PDF]

				E E Frezza, M S Wachtel, and M Chiriva-Internati Influence of obesity on the risk of developing colon cancer Gut, February 1, 2006; 55(2): 285 - 291. [Full Text] [PDF]

				H. M. Farin, F. Abbasi, and G. M Reaven Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults Am. J. Clinical Nutrition, January 1, 2006; 83(1): 47 - 51. [Abstract] [Full Text] [PDF]

				L. E. Eberly, R. Prineas, J. D. Cohen, G. Vazquez, X. Zhi, J. D. Neaton, L. H. Kuller, and for the Multiple Risk Factor Intervention Trial Re Metabolic Syndrome: Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial Diabetes Care, January 1, 2006; 29(1): 123 - 130. [Abstract] [Full Text] [PDF]

				L. Azadbakht, P. Mirmiran, A. Esmaillzadeh, T. Azizi, and F. Azizi Beneficial Effects of a Dietary Approaches to Stop Hypertension Eating Plan on Features of the Metabolic Syndrome Diabetes Care, December 1, 2005; 28(12): 2823 - 2831. [Abstract] [Full Text] [PDF]

				J. A. Morrison, L. A. Friedman, W. R. Harlan, L. C. Harlan, B. A. Barton, G. B. Schreiber, and D. J. Klein Development of the Metabolic Syndrome in Black and White Adolescent Girls: A Longitudinal Assessment Pediatrics, November 1, 2005; 116(5): 1178 - 1182. [Abstract] [Full Text] [PDF]

				T. Jiang, Z. Wang, G. Proctor, S. Moskowitz, S. E. Liebman, T. Rogers, M. S. Lucia, J. Li, and M. Levi Diet-induced Obesity in C57BL/6J Mice Causes Increased Renal Lipid Accumulation and Glomerulosclerosis via a Sterol Regulatory Element-binding Protein-1c-dependent Pathway J. Biol. Chem., September 16, 2005; 280(37): 32317 - 32325. [Abstract] [Full Text] [PDF]

				H. E. Lebovitz and M. A. Banerji Point: Visceral Adiposity Is Causally Related to Insulin Resistance Diabetes Care, September 1, 2005; 28(9): 2322 - 2325. [Full Text] [PDF]

				S. Camastra, M. Manco, A. Mari, S. Baldi, A. Gastaldelli, A. V. Greco, G. Mingrone, and E. Ferrannini {beta}-Cell Function in Morbidly Obese Subjects During Free Living: Long-Term Effects of Weight Loss Diabetes, August 1, 2005; 54(8): 2382 - 2389. [Abstract] [Full Text] [PDF]

				W. H. Xu, C. E. Matthews, Y. B. Xiang, W. Zheng, Z. X. Ruan, J. R. Cheng, Y. T. Gao, and X. O. Shu Effect of Adiposity and Fat Distribution on Endometrial Cancer Risk in Shanghai Women Am. J. Epidemiol., May 15, 2005; 161(10): 939 - 947. [Abstract] [Full Text] [PDF]

				S. Otake, H. Takeda, Y. Suzuki, T. Fukui, S. Watanabe, K. Ishihama, T. Saito, H. Togashi, T. Nakamura, Y. Matsuzawa, et al. Association of Visceral Fat Accumulation and Plasma Adiponectin with Colorectal Adenoma: Evidence for Participation of Insulin Resistance Clin. Cancer Res., May 15, 2005; 11(10): 3642 - 3646. [Abstract] [Full Text] [PDF]

				C. L Braunschweig, S. Gomez, H. Liang, K. Tomey, B. Doerfler, Y. Wang, C. Beebe, and R. Lipton Obesity and risk factors for the metabolic syndrome among low-income, urban, African American schoolchildren: the rule rather than the exception? Am. J. Clinical Nutrition, May 1, 2005; 81(5): 970 - 975. [Abstract] [Full Text] [PDF]

				D. C. Henderson, P. M. Copeland, T. B. Daley, C. P. Borba, C. Cather, D. D. Nguyen, P. M. Louie, A. E. Evins, O. Freudenreich, D. Hayden, et al. A Double-Blind, Placebo-Controlled Trial of Sibutramine for Olanzapine-Associated Weight Gain Am J Psychiatry, May 1, 2005; 162(5): 954 - 962. [Abstract] [Full Text] [PDF]

				L. M. Morimoto, P. A. Newcomb, E. White, J. Bigler, and J. D. Potter Insulin-like Growth Factor Polymorphisms and Colorectal Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1204 - 1211. [Abstract] [Full Text] [PDF]

				D. Gallagher, P. Kuznia, S. Heshka, J. Albu, S. B Heymsfield, B. Goodpaster, M. Visser, and T. B Harris Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue Am. J. Clinical Nutrition, April 1, 2005; 81(4): 903 - 910. [Abstract] [Full Text] [PDF]

				V. Sepilian and M. Nagamani Adiponectin Levels in Women With Polycystic Ovary Syndrome and Severe Insulin Resistance Reproductive Sciences, February 1, 2005; 12(2): 129 - 134. [Abstract] [PDF]

				V. Sepilian and M. Nagamani Effects of Rosiglitazone in Obese Women with Polycystic Ovary Syndrome and Severe Insulin Resistance J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 60 - 65. [Abstract] [Full Text] [PDF]

				G V Robinson, J R Stradling, and R J O Davies Sleep {middle dot} 6: Obstructive sleep apnoea/hypopnoea syndrome and hypertension Thorax, December 1, 2004; 59(12): 1089 - 1094. [Abstract] [Full Text] [PDF]

				C. Thamer, J. Machann, M. Haap, N. Stefan, E. Heller, B. Schnodt, M. Stumvoll, C. Claussen, A. Fritsche, F. Schick, et al. Intrahepatic Lipids Are Predicted by Visceral Adipose Tissue Mass in Healthy Subjects Diabetes Care, November 1, 2004; 27(11): 2726 - 2729. [Full Text] [PDF]

				B. E. Wisse The Inflammatory Syndrome: The Role of Adipose Tissue Cytokines in Metabolic Disorders Linked to Obesity J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2792 - 2800. [Abstract] [Full Text] [PDF]

				A. Garg Regional Adiposity and Insulin Resistance J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4206 - 4210. [Full Text] [PDF]

				C.-J. Tsai, M. F Leitzmann, W. C Willett, and E. L Giovannucci Prospective study of abdominal adiposity and gallstone disease in US men Am. J. Clinical Nutrition, July 1, 2004; 80(1): 38 - 44. [Abstract] [Full Text] [PDF]

				S. Klein, L. Fontana, V. L. Young, A. R. Coggan, C. Kilo, B. W. Patterson, and B. S. Mohammed Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease N. Engl. J. Med., June 17, 2004; 350(25): 2549 - 2557. [Abstract] [Full Text] [PDF]

				R. K. Bains, S. E. Wells, D. M. Flavell, K. M. Fairhall, M. Strom, P. Le Tissier, and I. C. A. F. Robinson Visceral Obesity without Insulin Resistance in Late-Onset Obesity Rats Endocrinology, June 1, 2004; 145(6): 2666 - 2679. [Abstract] [Full Text] [PDF]

				N. M. Morton, L. Ramage, and J. R. Seckl Down-Regulation of Adipose 11{beta}-Hydroxysteroid Dehydrogenase Type 1 by High-Fat Feeding in Mice: A Potential Adaptive Mechanism Counteracting Metabolic Disease Endocrinology, June 1, 2004; 145(6): 2707 - 2712. [Abstract] [Full Text] [PDF]

				I. Lemieux Energy Partitioning in Gluteal-Femoral Fat: Does the Metabolic Fate of Triglycerides Affect Coronary Heart Disease Risk? Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 795 - 797. [Full Text]

				N. M. Morton, J. M. Paterson, H. Masuzaki, M. C. Holmes, B. Staels, C. Fievet, B. R. Walker, J. S. Flier, J. J. Mullins, and J. R. Seckl Novel Adipose Tissue-Mediated Resistance to Diet-Induced Visceral Obesity in 11{beta}-Hydroxysteroid Dehydrogenase Type 1-Deficient Mice Diabetes, April 1, 2004; 53(4): 931 - 938. [Abstract] [Full Text] [PDF]